Clinical Trial Update: BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating BK virus as a potential etiologic agent for salivary gland disease with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Lymphoepithelial Lesion
• HIV Infection
• Salivary Gland Disease

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV, Salivary Gland Disease | Phase 3 | Status: COMPLETED | Results posted: 2019-07-11